6 Analysts Have This to Say About Chemours
Portfolio Pulse from Benzinga Insights
In the last quarter, Chemours (NYSE:CC) received 1 somewhat bullish and 5 indifferent ratings from analysts. The average 12-month price target for the company is $38.33, a 6.12% decrease from the previous average of $40.83.

October 04, 2023 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Chemours received mostly indifferent ratings from analysts, with a 12-month price target of $38.33, indicating a potential decrease in stock price.
The majority of analysts gave Chemours indifferent ratings, indicating a lack of strong positive sentiment towards the company's stock. The decrease in the average 12-month price target suggests that analysts expect the stock price to potentially decrease in the future.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100